Literature DB >> 18220553

Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.

Jigisha K Varia1, Shamsunder S Dodiya, Krutika K Sawant.   

Abstract

Solid lipid nanoparticles (SLNs) loaded with Cyclosporine A using glyceryl monostearate (GMS) and glyceryl palmitostearate (GPS) as lipid matrices were prepared by melt-homogenization using high-pressure homogenizer. Various process parameters such as homogenization pressure, homogenization cycles and formulation parameters such as ratio of drug: lipid, emulsifier: lipid and emulsifier: co-emulsifier were optimized using particle size and entrapment efficiencies as the dependent variables. The mean particle size of optimized batches of the GMS SLN and GPS SLN were found to be 131 nm and 158 nm and their entrapment efficiencies were 83 +/- 3.08% and 97 +/- 2.59% respectively. To improve the handling processing and stability of the prepared SLNs, the SLN dispersions were spray dried and its effect on size and reconstitution parameters were evaluated. The spray drying of SLNs did not significantly alter the size of SLNs and they exhibited good redispersibility. Solid state studies such as Infra Red Spectroscopy and Differential Scanning Calorimetry indicated absence of any chemical interaction between Cyclosporine A and the lipids. Scanning Electron Microscopy of optimized formulations showed spherical shape with smooth and non porous surface. In vitro release studies revealed that GMS based SLNs released the drug faster (41.12% in 20 hours) than GPS SLNs (7.958% in 20 hours). Release of Cyclosporine A from GMS SLN followed Higuchi equation better than first order while release from GPS SLN followed first order better than Higuchi model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220553     DOI: 10.2174/156720108783331069

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  6 in total

1.  Evaluation of the peripheral analgesic effect of sufentanil lipid nanoparticles.

Authors:  Hongjun Li; Hui Qiao; Hongjie Lu; Changqi Liu
Journal:  J Anesth       Date:  2014-03-07       Impact factor: 2.078

Review 2.  Recent advances in cyclosporine drug delivery: challenges and opportunities.

Authors:  Dhrumi Patel; Sarika Wairkar
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

3.  Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method.

Authors:  Zaida Urbán-Morlán; Adriana Ganem-Rondero; Luz María Melgoza-Contreras; José Juan Escobar-Chávez; María Guadalupe Nava-Arzaluz; David Quintanar-Guerrero
Journal:  Int J Nanomedicine       Date:  2010-09-07

4.  Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

Authors:  Patrícia Severino; Tatiana Andreani; Ana Sofia Macedo; Joana F Fangueiro; Maria Helena A Santana; Amélia M Silva; Eliana B Souto
Journal:  J Drug Deliv       Date:  2011-11-24

5.  Freeze-Dried Softisan® 649-Based Lipid Nanoparticles for Enhanced Skin Delivery of Cyclosporine A.

Authors:  Maria Inês Silva; Ana Isabel Barbosa; Sofia A Costa Lima; Paulo Costa; Tiago Torres; Salette Reis
Journal:  Nanomaterials (Basel)       Date:  2020-05-21       Impact factor: 5.076

6.  Solid Lipid Nanoparticles of Atovaquone Based on 2(4) Full-Factorial Design.

Authors:  Noratiqah Mohtar; Nurzalina A K Khan; Yusrida Darwis
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.